Drug
Gadobenic acid clinical trials
Also written MultiHance and Gadobenate dimeglumine.
- studies test it
- 17
- open now
- 1
- in phase 3
- 5
- first study started
- 2006
Keep track of what changes. Save the gadobenic acid studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
17 studies that test it; most in 2006 (6)
| Year | Studies |
|---|---|
| 2006 | 6 |
| 2007 | 2 |
| 2009 | 2 |
| 2011 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 2
- Phase 3
- 5
- Phase 4
- 5
- No phase
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 10 · Other 7
Bracco Diagnostics, Inc (9) · University of Wisconsin, Madison (1) · M.D. Anderson Cancer Center (1) · University of Utah (1) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1) · Guerbet (1) · University of Colorado, Denver (1) · University of Southern California (1)
Often tested with
Tested in the same studies.
Gadolinium DTPA (4) · Gadobutrol (2) · Gadolinium ethoxybenzyl DTPA (2) · Gadodiamide (1)
Studies
Open first, then newest update. How each study uses gadobenic acid is read from its arms, and is right about nine times in ten.
Testing it · 17
- Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 YearsRecruitingPhase 4GuerbetNCT04373564Written as Gadobenate dimeglumine
- Comparison of Contrast Agents in Liver Magnetic Resonance (MR) for the Detection of Hepatic MetastasesTerminatedPhase 4University of Colorado, DenverNCT04973007Written as Gadobenate dimeglumine
- Hybrid Molecular Imaging of ER in Breast Cancer Patients With DCISCompletedPhase 2University of Wisconsin, MadisonNCT03703492Written as Gadobenate dimeglumine
- Renal MRA Crossover Study Comparing Multihance to Another Contrast AgentCompletedPhase 3Bracco Diagnostics, IncNCT00415805Written as Multihance
- Novel MRI Techniques for the Characterization and Treatment Assessment of High Grade Brain LesionsCompletedNot applicableM.D. Anderson Cancer CenterNCT04132843Written as Gadobenate Dimeglumine
- Multihance at 3 Tesla (3T) in Brain TumorsCompletedPhase 4Bracco Diagnostics, IncNCT00395863Written as Multihance
- Regadenoson Stress-MRI to Identify Coronary Artery Disease in Atrial Fibrillation PatientsCompletedPhase 2University of UtahNCT01710254Written as Gadobenate dimeglumine
- Assessment of Liver Cancer Response to TACE Using MultiHance-Enhanced MRI.CompletedNot applicableSidney Kimmel Comprehensive Cancer Center at Johns HopkinsNCT00539253Written as gadobenate dimeglumine (MultiHance)
- Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain MetastasesTerminatedNot applicableUniversity of Southern CaliforniaNCT02967380Written as Gadobenate Dimeglumine
- Acute Heart Graft Rejection Screening by Cardiac Magnetic Resonance ImagingWithdrawnNot applicableUniversity Hospital, RouenNCT02400840Written as gadobenic acid intravenous injection 0.2 ml/kg
- Study to Compare MultiHance With Gadovist in Magnetic Resonance Imaging (MRI) of the BrainCompletedPhase 4Bracco Diagnostics, IncNCT00907530Written as MULTIHANCE:
- Crossover Comparison of Two Gadolinium Contrast Agents for Use With MRA of Carotid, Renal and Peripheral ArteriesCompletedPhase 3Bracco Diagnostics, IncNCT01260636Written as Gadobenate Dimeglumine
- Safety and Efficacy of MultiHance in Pediatric PatientsTerminatedPhase 3Bracco Diagnostics, IncNCT00323310Written as gadobenate dimeglumine
- Multihance Versus Magnevist in Breast MRICompletedPhase 3Bracco Diagnostics, IncNCT00486473Written as Multihance
- Crossover Study With MultiHance vs a Comparator for Peripheral MRACompletedPhase 3Bracco Diagnostics, IncNCT00408083Written as MultiHance
- A Study Comparing Two Magnetic Resonance Imaging (MRI) Contrast Agents in MRI of the BrainCompletedPhase 4Bracco Diagnostics, IncNCT00323102Written as Multihance
- A Pharmacokinetics Study of MultiHance in Pediatric PatientsCompletedPhase 1Bracco Diagnostics, IncNCT00411931Written as Multihance
Given in every arm · 2 — gadobenic acid is usual care beside what is tested
- PSMA-Targeted 18F-DCFPyL PET/MRI for the Detection of Prostate CancerWithdrawnPhase 2Northwestern UniversityNCT04910425Written as Gadobenate Dimeglumine
- P03277 Dose Finding Study in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)CompletedPhase 2GuerbetNCT02633501Written as Gadobenate dimeglumine
As the comparator · 1 — what is tested is compared with gadobenic acid
Codes
What other systems call gadobenic acid · ClinicalTrials.gg INT003520
- MeSH (NLM) C064572gadobenic acidConfirmed NLM, Wikidata
- UNII (FDA) 15G12L5X8KGADOBENIC ACIDConfirmed FDA, NLM, Wikidata
- RxNorm 692620One source FDA
- Wikidata Q5516409gadobenic acidConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C76043Gadobenic AcidOne source FDA
- DrugBank DB00743One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C064572 | gadobenic acid | Confirmed NLM, Wikidata |
| UNII (FDA) | 15G12L5X8K | GADOBENIC ACID | Confirmed FDA, NLM, Wikidata |
| RxNorm | 692620 | — | One source FDA |
| Wikidata | Q5516409 | gadobenic acid | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C76043 | Gadobenic Acid | One source FDA |
| DrugBank | DB00743 | — | One source Wikidata |
Also registered as gadobenate dimeglumine (UNII 3Q6PPC19PO · RxNorm 68173).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.